Advanced Search

 

Study ID Status Title Patient Level Data
201 Completed Single-Dose Bioequivalence of WELLBUTRIN® Sustained-Release Tablets Versus WELLBUTRIN Immediate-Release Tablets in Healthy Male Volunteers: A Pilot Study
201003 Completed An open-label study in healthy male subjects, to determine the excretion balance and pharmacokinetics of [14C]-GSK961081, administered as a single intravenous microtracer (concomitant with an inhaled non-radiolabelled dose) and a single oral dose
201010 Completed An open label, randomised, six-way crossover, single dose study to determine the pharmacokinetics of GSK961081 and fluticasone furoate when administered alone or in combination Study Listed on ClinicalStudyDataRequest.com
201011 Completed An open-label, randomised, single dose, two-way crossover pilot study to determine the relative bioavailability of one 16mg tablet formulation of candesartan cilexetil (GW615775) relative to one 16mg reference tablet of candesartan cilexetil (Atacand) in healthy adult human subjects under fasting conditions
201012 Completed Study 201012: A Dose-Finding Study of batefenterol (GSK961081) via Dry Powder Inhaler in Patients with COPD
201022 Completed A Two Part, Phase I, Randomized, Placebo Controlled, Double Blind Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects Protocol 201022 Study Listed on ClinicalStudyDataRequest.com
201037 Completed A Single Centre, Open-label, 5-Period, Cross over, Randomized Study in Healthy Elderly Subjects to Evaluate the Relative Bioavailability of Hydrobromide Salt and Free Base Immediate Release Tablet Formulations of Danirixin in the Fed State, and to Evaluate the Effect of Food and Gastric Acid Secretion Suppression on Danirixin Pharmacokinetics Following Administration of Hydrobromide Salt Tablets
201039 Completed A Single Center, Randomized, Open-Label, Sequential, Single Dose, 3-Period Crossover Study to Evaluate the Bioavailability and Food Effect of a Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib, an AKT Inhibitor, in Normal Healthy Volunteers
201065 Completed PGx7558: An Exploratory Study of Genetic Effects on Anoro (GSK573719/GW642444) in Chronic Obstructive Pulmonary Disease in Multiple Clinical Studies
201066 Completed PGx6712: An Exploratory Study of the Effects of 2 Common Variants in ADRB2 on Anoro (GSK573719/GW642444) Efficacy in Chronic Obstructive Pulmonary Disease in Multiple Clinical Studies
201071 Completed An open-label study of the correct use and ease of use of placebo ELLIPTA dry powder inhaler in subjects with chronic obstructive pulmonary disease (COPD)
201072 Completed An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccine(s) GSK3206641A and GSK3206640A administered in adults 18 to 64 years of age Study Listed on ClinicalStudyDataRequest.com
201092 Completed A Randomised, Open-Label, Four Period, Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate from FLIXOTIDE™ 250 HFA pMDI and of Fluticasone Propionate and Salmeterol from SERETIDE™ 250/25 HFA pMDI when given with the VENTOLIN Mini-Spacer Compared to the Aerochamber Plus Spacer in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
201102 Completed A Phase 1, Open-Label, Crossover Study to Evaluate the Drug Interaction Between Dolutegravir and Daclatasvir in Healthy Adult Subjects
201109 Terminated WEUSKOP7134: PASS HCV Research UK: Prospective observational cohort study to explore the safety and effectiveness of eltrombopag in a real-world setting in adult patients with chronic hepatitis C virus infection who are unable to initiate or maintain optimal interferon-based therapy due to thrombocytopenia nested within the HCV Research UK National Registry
201114 Active, Not Recruiting Reasons for discontinuation of injectable diabetes medications: wave 2
201120 Completed A Phase IIa Study to Evaluate the Safety, Tolerability and Acceptability of Long Acting Injections of the HIV Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
201121 Not yet recruiting Epidemiological study assessing the Burden of Illness related to COPD exacerbations in Québec
201131 Completed A randomised, double-blind, study to investigate the effects of creatine supplementation on muscle energetics and cognitive function in young healthy male athletes and an ageing population using phosphorus-31 magnetic resonance spectroscopy (31P MRS) and functional magnetic resonance imaging (fMRI)
201133 Completed A methodology study to evaluate a sitting knee measuring device in assessing growth in Indian children aged 6 to 12 years receiving nutritional supplement with or without micronutrient fortification
201135 Completed 201135 : A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily with Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down from a Maintenance Therapy with RELVAR® inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects Study Listed on ClinicalStudyDataRequest.com
201147 Completed 201147: a Phase IIIb, randomized, open-label study of the safety, efficacy, and tolerability of switching to a fixed-dose combination of abacavir/dolutegravir/ lamivudine from current antiretroviral regimen compared with continuation of the current antiretroviral regimen in HIV-1 infected adults who are virologically suppressed, The STRIIVING Study.
201152 Active, Not Recruiting Indirect treatment comparisons of Ph3 combination studies for dabrafenib plus trametinib versus other treatments
201153 Completed Updated analyses adjusting for treatment crossover in Part C of a Phase 2 trial (BRF113220) of dabrafenib and trametinib combination therapy in patients with metastatic melanoma based on recent dataset (March 2013)
201159 Completed A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.